1612 — Vincent Medical Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$606.52m
- HK$541.58m
- HK$932.78m
Annual income statement for Vincent Medical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 778 | 629 | 718 | 801 | 933 |
| Cost of Revenue | |||||
| Gross Profit | 259 | 165 | 240 | 260 | 327 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 703 | 640 | 652 | 721 | 803 |
| Operating Profit | 74.5 | -11 | 65.8 | 79.7 | 130 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 66.2 | -15.5 | 66.9 | 78 | 130 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 60.1 | -18.4 | 58.2 | 70.9 | 108 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 60.7 | -17.4 | 57.3 | 69.2 | 104 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 60.7 | -17.4 | 57.3 | 69.2 | 104 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.111 | -0.022 | 0.09 | 0.111 | 0.17 |
| Dividends per Share | |||||
| Special Dividends per Share |